Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffery Talbert

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Addiction (Abingdon, England)|June 2, 2022
Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort studyMarguerite Burns, Lu Tang, Chung-Chou H Chang, et al.
Drug and Alcohol Dependence|June 7, 2025
HEALing Communities Study: Data measures for supporting a community-based intervention to reduce opioid overdose deathsSvetla Slavova, Jennifer Villani, Daniel J Feaster, et al.
Medical Care|July 15, 2022
Design, Implementation, and Evolution of the Medicaid Outcomes Distributed Research Network (MODRN)Kara Zivin, Lindsay Allen, Andrew J Barnes, et al.
JAMA|July 13, 2021
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018, Julie M Donohue, Marian P Jarlenski, et al.
JAMA Health Forum|June 16, 2023
Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid ProgramsAnna E Austin, Lu Tang, Joo Yeon Kim, et al.
Journal of Substance Use and Addiction Treatment|March 6, 2026
Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020Julie Donohue, Bill Wang, Lu Tang, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
JAMA Network Open|February 22, 2024
Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical TrialThomas J Stopka, Denise C Babineau, Erin B Gibson, et al.
PLOS Digital Health|April 15, 2024
Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort studyMeghan R Hutch, Jiyeon Son, Trang T Le, et al.
PLOS Digital Health|July 22, 2025
Correction: Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort studyMeghan R Hutch, Jiyeon Son, Trang T Le, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Addiction (Abingdon, England)|June 2, 2022
Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort studyMarguerite Burns, Lu Tang, Chung-Chou H Chang, et al.
Drug and Alcohol Dependence|June 7, 2025
HEALing Communities Study: Data measures for supporting a community-based intervention to reduce opioid overdose deathsSvetla Slavova, Jennifer Villani, Daniel J Feaster, et al.
Medical Care|July 15, 2022
Design, Implementation, and Evolution of the Medicaid Outcomes Distributed Research Network (MODRN)Kara Zivin, Lindsay Allen, Andrew J Barnes, et al.
JAMA|July 13, 2021
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018, Julie M Donohue, Marian P Jarlenski, et al.
JAMA Health Forum|June 16, 2023
Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid ProgramsAnna E Austin, Lu Tang, Joo Yeon Kim, et al.
Journal of Substance Use and Addiction Treatment|March 6, 2026
Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020Julie Donohue, Bill Wang, Lu Tang, et al.
Drug and Alcohol Dependence|April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trialLaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
JAMA Network Open|February 22, 2024
Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical TrialThomas J Stopka, Denise C Babineau, Erin B Gibson, et al.
PLOS Digital Health|April 15, 2024
Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort studyMeghan R Hutch, Jiyeon Son, Trang T Le, et al.
PLOS Digital Health|July 22, 2025
Correction: Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort studyMeghan R Hutch, Jiyeon Son, Trang T Le, et al.
Pageof 6